Xarelto: the Hidden Dangers

Xarelto, also known as rivaroxaban, is a blood thinner that is used to reduce the risk of strokes, prevent the formation of blood clots, and treat deep vein thrombosis (DVT), which can ultimately lead to a pulmonary embolism, a blood clot in the lungs.

bayerSince 2011, when the FDA first approved Xarelto, the manufacture pharmaceutical companies, Bayer AG and Janssen Pharmaceuticals (a Johnson and Johnson’s subsidiary), have made millions of dollars by selling Xarelto, however thousands of people have been gravely injured by Xarelto’s adverse side effects. Patients claimed that they were not properly warned about the faulty drug’s risks, which include uncontrollable and irreversible internal bleeding, to which there is no effective antidote available.

In May 2016, Safety Labeling Changes for Xarelto were approved by FDA Center for Drug Evaluation and Research (CDER). The summary view is below. For a more detailed view, please visit: (http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm367392.htm)

 

drug safety changes-complete

If you or a loved one has suffered from uncontrollable internal bleeding or other side effects after taking this blood thinner, or if you have lost a loved one due to bleeding after taking Xarelto, you might be entitled to compensation. Contact the Madeksho Law Firm, PLLC at 1-800—432-6048.